Cerebrovascular Disorders D002561

Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Cerebrovascular Disorders

Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Cerebrovascular Disorders

Description

A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.   MeSH

Subtype Terms (17)

Basal Ganglia Cerebrovascular Disease
1 experimental drug

Brain Ischemia
219 drugs (106 approved, 113 experimental)

Carotid Artery Diseases
78 drugs (55 approved, 23 experimental)

Cerebral Small Vessel Diseases
74 drugs (46 approved, 28 experimental)

Cerebrovascular Trauma
8 approved drugs

Dementia, Vascular
45 drugs (28 approved, 17 experimental)

Intracranial Arterial Diseases
117 drugs (78 approved, 39 experimental)

Intracranial Arteriovenous Malformations
3 approved drugs

Intracranial Embolism and Thrombosis
11 drugs (7 approved, 4 experimental)

Intracranial Hemorrhages
167 drugs (117 approved, 50 experimental)

Leukomalacia, Periventricular
13 drugs (11 approved, 2 experimental)

Sneddon Syndrome
 

Stroke
404 drugs (200 approved, 204 experimental)

Susac Syndrome
 

Vascular Headaches
3 approved drugs

Vasculitis, Central Nervous System
41 drugs (33 approved, 8 experimental)

Vasospasm, Intracranial
22 drugs (20 approved, 2 experimental)


Phase 4 Indicated Drugs (150)

Key: D002561 (7) Subtype (143)

Phase 3 Indicated Drugs (151)

Key: D002561 (12) Subtype (139)

Phase 2 Indicated Drugs (198)

Key: D002561 (6) Subtype (192)


Organization Involved with Phase 4 Indications (179)

Key: D002561 (7) Subtype (172)

Organization Involved with Phase 3 Indications (194)

Key: D002561 (10) Subtype (184)

Organization Involved with Phase 2 Indications (185)

Key: D002561 (10) Subtype (175)

Organization Involved with Phase 1 Indications (52)

Organization Involved with Other Experimental Indications (61)

Key: D002561 (0) Subtype (61)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.